The U.S. Food and Drug Administration's (FDA) Psychopharmacologic Drugs Advisory Committee voted against recommending a new drug application (NDA) submitted by Lykos Therapeutics to use midomafetamine (MDMA) capsules in combination...
The post FDA Committee Opposes Lykos NDA For MDMA-Assisted Treatment For PTSD appeared first on OPEN MINDS.